Upstream and Downstream Processing of Lovastatin by Aspergillus terreus

Cell Biochemistry and Biophysics

Volumn 70, Issue 1, 2014, Pages 309-320

  Mukhtar, Hamid ^a   Ijaz, Syeda Sidra ^a   Ikram ul Haq, ^a  

^a GC UNIVERSITY   (Pakistan)

Author keywords

Crystal analysis; Downstream processing; Fermentation; Lipid lowering; Mutagenesis

Indexed keywords

ASPERGILLUS TERREUS; ZEA MAYS;

CARBON; MEVINOLIN; NITROGEN; NITROUS ACID;

ASPERGILLUS; BATCH CELL CULTURE; BIOREACTOR; BIOSYNTHESIS; CHEMISTRY; DRUG EFFECTS; FERMENTATION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MUTAGENESIS; PH; RADIATION RESPONSE; TEMPERATURE; TIME; ULTRAVIOLET RADIATION;

ASPERGILLUS; BATCH CELL CULTURE TECHNIQUES; BIOREACTORS; CARBON; FERMENTATION; HYDROGEN-ION CONCENTRATION; LOVASTATIN; MUTAGENESIS; NITROGEN; NITROUS ACID; TEMPERATURE; TIME FACTORS; ULTRAVIOLET RAYS;

EID: 84906264636     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-014-9914-7     Document Type: Article

References (48)

1. Alberts, A. W., Chen, J., Kuron, G., Hunt, V., Huff, J., Hoffman, C., et al. (1980). Mevinolin: A highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme a reductase and a cholesterol-lowering agent. Proceedings of National Academy of Sciences, 77, 3957-3961.
2. Alvarez-Lueje, A., Pastine, J., Squella, J. A., & Nunez-Vergara, L. J. (2005). Assessment of the hydrolytic degradation of lovastatin by HPLC. Journal of the Chilean Chemical Society, 50, 639-646.
3. Atalla, M. M., Hamed, E. R., & El-Shami, A. R. (2008). Optimization of a culture medium for increased mevinolin production by Aspergillus terreus strain. The Malaysian Journal of Microbiology, 4(2), 6-10.
4. Bizukojc, M., & Ledakowicz, S. (2008). Biosynthesis of lovastatin and (+)-geodin by Aspergillus terreus in batch and fed-batch culture in the stirred tank bioreactor. Biochemical Engineering Journal, 42, 198-207.
5. Brown, A. G., Smale, T. C., King, T. J., Hasenkamp, R., & Thomson, R. H. (1976). Crystal and molecular structure of compactin, a new antifungal metabolite from Penicillium brevicompactum. Journal of the Chemical Society. Perkin transactions 1, 1, 1165-1170.
6. Buckland, B., Gbewonyo, K., Hallada, T., Kaplan, L., & Masurekar, P. (1989). Production of lovastatin, an inhibitor of cholesterol accumulation in humans. In A. L. Demain, G. A. Somkuti, J. C. Hunter-Cevera, & H. W. Rossmoore (Eds.), Novel microbial products for medicine and agriculture (pp. 161-169). Amsterdam: SIM Publication.
7. Dekleva, M. L., Titus, J. A., & Strohl, W. R. (1985). Nutrient effects on anthracycline production by Streptomyces peucetius in a defined medium. Canadian Journal of Microbiology, 31(3), 287-294.
8. Eckert, G. P., Wood, W. G., & Muller, W. E. (2005). Statins: Drugs for Alzheimer's disease. The Journal of Neural Transmission, 112, 1057-1071.
9. Endo, A. (1979). Monacolin K: A new hypocholesterolemic agent produced by Monascus spp. Journal of Antibiotics, 32, 852-854.
10. Endo, A., Kuroda, M., & Tanazawa, K. (1976). Competitive inhibition of 3-hydroxy-3-methyl glutaryl coenzyme A reductase by ML-236 A and ML-236 B fungal metabolites having hypocholesterolemic activity. FEBS Letters, 72, 323-326.
11. Friedrich, J., Zuzek, M., Bencina, M., Cimerman, A., Strancer, A., & Radez, I. (1995). High-performance liquid chromatographic analysis of mevinolin as mevinolinic acid in fermentation broths. The Journal of Chromatography A, 704, 363-367.
12. Garrett, I. R., Gutierrez, G. E., Rossini, G., Nyman, J., McCluskey, B., & Flores, A. (2007). Locally delivered lovastatin nanoparticles enhance fracture healing in rats. Journal of Orthopaedic Research, 25, 1351-1357.
13. Grahek, R., Milivojevic, D., Bastarda, A., & Kracun, M. (2001). Chromatographic purification of some 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. The Journal of Chromatography A, 918, 319-324.
14. Hajjaj, H., Niedberger, P., & Duboc, P. (2001). Lovastatin biosynthesis by Aspergillus terreus in a chemically defined medium. Applied and Environment Microbiology, 67, 2596-2604.
15. Hollaender, A., Sansome, E., Zimmer, E., & Demerec, M. A. (1945). Quantitative irradiation experiments on Neurospora crassa. Il. Ultraviolet irradiation. The American Journal of Botany, 32, 226-235.
16. Hollaender, A., Raper, K. B., & Coghill, R. D. (1945). The production and characterization of ultraviolet-induced mutations in Aspergillus terreus. I. Production of the mutations. The American Journal of Botany, 32(3), 160-165.
17. Juzlov, P., Martinkova, L., & Kren, V. (1996). Secondary metabolites of the fungus Monascus: A review. The Journal of Industrial Microbiology, 16, 163-170.
18. Kumar, M. S., Jana, S. K., Senthil, V., Shashanka, V., Kumar, S. V., & Sadhukhan, A. K. (2000). Repeated fed-batch process for improving lovastatin production. Process Biochemistry, 36, 363-368.
19. Kumar, M. S., Kumar, P. M., Sarnaik, H. M., & Sadhukhan, A. K. (2000). A rapid technique for screening of lovastatin-producing strains of Aspergillus terreus by agar plug and Neurospora crassa bioassay. Journal of Microbiological Methods, 40, 99-104.
20. Kumar, V. S., Harishchandra, T. B. and Rajaram, K. S. (2005). A method for the manufacture of lovastatin. European Patent Specification, EP 1 673 361 B1.
21. Lai, L. S. T., Pan, C. C., & Tzeng, B. K. (2003). The influence of medium design on lovastatin production and pellet formation with a high-producing mutant of Aspergillus terreus in submerged cultures. Process Biochemistry, 38, 1317-1326.
22. Lai, L. S. T., Tsai, T. H., Wang, T. C., & Cheng, T. Y. (2005). The influence of culturing environments on lovastatin production by Aspergillus terreus in submerged cultures. Enzyme and Microbial Technology, 36, 737-748.
23. Lockwood, L. B., Raper, K. B., Moyer, A. J., & Coghill, R. D. (1945). The production and characterization of ultraviolet induced mutations in Aspergillus terreus. III. Biochemical characteristics of the mutation. The American Journal of Botany, 52, 214-217.
24. Lopez, J. L. C., Perez, J. A. S., Sevilla, J. M. F., Fernandez, F. G. A., Grima, E. M., & Chisti, Y. (2003). Production of lovastatin by Aspergillus terreus: Effects of the C: N ratio and the principal nutrients on growth and metabolite production. Enzyme and Microbial Technology, 33, 270-277.
25. Lopez, J. L. C., Porcel, E. M. R., Ferron, M. A. V., Perez, J. A. S., Sevilla, J. M. F., & Chisti, Y. (2004). Lovastatin inhibits its own synthesis in Aspergillus terreus. Journal of Industrial Microbiology and Biotechnology, 31, 48-50.
26. Lopez, J. L. C., Perez, J. A. S., Sevilla, J. M. F., Porcel, E. M. R., & Chisti, Y. (2005). Pellet morphology, culture rheology and lovastatin production in cultures of Aspergillus terreus. Journal of Biotechnology, 116, 61-77.
27. Mala, J. G. S., Kamini, R. N. R., & Puvanakrishnan, R. (2001). Strain improvement of Aspergillus niger for enhanced lipase production. Journal of General and Applied Microbiology, 47, 181-186.
28. Manzoni, M., Rollini, M., Bergomi, S., & Cavazzoni, V. (1998). Production and purification of statins from Aspergillus terreus strains. Biotechnology Techniques, 12, 529-532.
29. Manzoni, M., & Rollini, M. (2002). Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs. Applied Microbiology and Biotechnology, 58, 555-564.
30. Negishi, S., Haung, Z. C., Hasumi, K., Murakawa, S., & Endo, A. (1986). Productivity of monacolin K (mevinolin) in the genus Monascus. Hakko Kogaku Kaishi, 64(6), 509-512.
31. Novak, N., Gerdin, S., & Berovic, M. (1997). Increased lovastatin formation by Aspergillus terreus using repeated fed-batch process. Biotechnology Letters, 19, 947-948.
32. Rajh, S. J., Kreft, S., Strukelj, B., & Vrecer, F. (2003). Comparison of CE and HPLC methods for determining lovastatin and its oxidation products after exposure to an oxidative atmosphere. Croatica Chemica Acta, 76, 263-268.
33. Raper, K. B., Coghill, R. D., & Hollaender, A. (1945). The production and characterization of ultraviolet-induced mutations in Aspergillus terreus. II. Cultural and morphological characteristics of the mutations. The American Journal of Botany, 32(3), 165-176.
34. Roze, L. V., & Linz, J. E. (1998). Lovastatin triggers an apoptosis-like cell death process in fungus Mucor racemosus. Fungal Genetics and Biology, 25(2), 119-133.
35. Samiee, S. M., Moazami, N., Haghighi, S., Mohseni, F. A., Mirdamadi, S., & Bakhtiari, M. R. (2003). Screening of lovastatin production by filamentous fungi. Iran Biomedical Journal, 7(1), 29-33.
36. Sayyad, S. A., Panda, B. P., Javed, S., & Ali, M. (2007). Optimization of nutrient parameters for lovastatin production by Monascus purpureus MTCC 369 under submerged fermentation using response surface methodology. Applied Microbiology and Biotechnology, 73, 1054-1058.
37. Siddiqi, O. H. (1962). Mutagenic action of nitrous acid on Aspergillus nidulans. Genetical Research, 3, 303-314.
38. Smith, D. C., & Wood, T. M. (1991). Isolation of mutants of Aspergillus awamori with enhanced production of extracellular xylanase and β-xylosidase. World Journal of Microbiology and Biotechnology, 7, 343-354.
39. Snedecor, G. W., & Cochran, W. G. (1980). Statistical methods (7th ed., pp. 32-43). Iowa State University.
40. Steinberg, R. A., & Thom, C. (1940). Chemical induction of genetic changes in Aspergilli. Journal of Heredity, 31, 61-63.
41. Steinberg, R. A., & Thom, C. (1940). Mutations and reversions in reproductivity of Aspergilli with nitrite, cochicine and d-lysine. Proceedings of the National Academy of Sciences, 26, 363-366.
42. Su, Y. C., Wang, J. J., Lin, T. T., & Pan, T. M. (2003). Production of secondary metabolites, alpha-amino butyric acid and monacolin K by Monascuc anka. Journal of Industrial Microbiology and Biotechnology, 30, 41-46.
43. Szakacs, G., Morovjan, G., & Tengerdy, R. P. (1998). Production of lovastatin by a wild strain of Aspergillus terreus. Biotechnology Letters, 20, 411-415.
44. Valera, H. R., Gomes, J., Lakshmi, S., Gruraja, R., Suryanarayan, S., & Kumar, D. (2005). Lovastatin production by solid state fermentation using Aspergillus flavipes. Enzyme and Microbial Technology, 37, 521-526.
45. Vinci, V. A., Hoerner, T. D., Coffman, A. D., Schimmel, T. G., Dabora, R. L., Kirpekar, A. C., et al. (1991). Mutants of lovastatin-hyperproducing Aspergillus terreus deficient in the production of sulochrin. Journal of Industrial Microbiology, 8, 113-120.
46. Wang, J. J., Lee, C. L., & Pan, T. M. (2003). Improvement of monacolin K, alpha-amino acid and citrinin production ratio as a function of environmental condition of Monascus purpureus NTU 601. Journal of Industrial Microbiology and Technology, 30, 669-676.
47. Youssef, S., Stuve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., & Hur, E. M. (2002). The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature, 420, 78-84.
48. Zaghloul, T. I., Embaby, A. M., & Elmahdy, A. R. (2011). Biodegradation of chicken feathers waste directed by Bacillus subtilis recombinant cells: Scaling up in a laboratory scale fermentor. Bioresource Technology, 102(3), 2387-2393.